Cover Image

Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII

A range of 3H-1,2-benzoxaphosphepine 2-oxide aryl derivatives with various substitution patterns at positions 7, 8, or 9 of the scaffold was synthesised in five steps from the commercially available salicylaldehydes. All of the newly obtained compounds were studied for their inhibition potency again...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anastasija Balašova (Author), Aleksandrs Pustenko (Author), Alessio Nocentini (Author), Daniela Vullo (Author), Claudiu T. Supuran (Author), Raivis Žalubovskis (Author)
Format:	Book
Published:	Taylor & Francis Group, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

3H-1,2-Benzoxaphosphepine 2-oxides as selective inhibitors of carbonic anhydrase IX and XII
by: Aleksandrs Pustenko, et al.
Published: (2023)

7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II
by: Jekaterīna Ivanova, et al.
Published: (2023)

The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2020)

3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors
by: Aleksandrs Pustenko, et al.
Published: (2017)

Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
by: Mikhail Krasavin, et al.
Published: (2020)

1,2,3-Benzoxathiazine-2,2-dioxides - effective inhibitors of human carbonic anhydrases
by: Jekaterina Ivanova, et al.
Published: (2023)

Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
by: Wagdy M. Eldehna, et al.
Published: (2022)

Organoruthenium(II) complexes of acetazolamide potently inhibit human carbonic anhydrase isoforms I, II, IX and XII
by: Sara Seršen, et al.
Published: (2019)

Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII
by: Tarfah Al-Warhi, et al.
Published: (2022)

Selenium-analogs based on natural sources as cancer-associated carbonic anhydrase isoforms IX and XII inhibitors
by: Nora Astrain-Redin, et al.
Published: (2023)

Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies
by: Ciro Milite, et al.
Published: (2019)

Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold
by: Romeo Romagnoli, et al.
Published: (2023)

Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms
by: Melissa D'Ascenzio, et al.
Published: (2017)

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors
by: Simone Giovannuzzi, et al.
Published: (2023)

2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms
by: Lisa Sequeira, et al.
Published: (2023)

2-((1H-Benzo[d]imidazol-2-yl)amino)benzo[d]thiazole-6-sulphonamides: a class of carbonic anhydrase II and VII-selective inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
by: Zainab M. Elsayed, et al.
Published: (2023)

Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors
by: P. V. Sri Ramya, et al.
Published: (2017)

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
by: Mateusz Kciuk, et al.
Published: (2022)

Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies
by: Gianmarco Gualtieri, et al.
Published: (2023)

Vanillin enones as selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII. The out of the active site pocket for the design of selective inhibitors?
by: Leonardo E. Riafrecha, et al.
Published: (2021)

Synthesis, computational studies and assessment of in vitro inhibitory activity of umbelliferon-based compounds against tumour-associated carbonic anhydrase isoforms IX and XII
by: Francesca Mancuso, et al.
Published: (2020)

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
by: Chiara Testa, et al.
Published: (2022)

A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors
by: Rakia Abd Alhameed, et al.
Published: (2020)

4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies
by: Hossam Nada, et al.
Published: (2022)

Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
by: Mohamed A. Abdelrahman, et al.
Published: (2020)

Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives
by: Gustavo Provensi, et al.
Published: (2021)

Isocoumarins: a new class of selective carbonic anhydrase IX and XII inhibitors
by: Mehmet Onyılmaz, et al.
Published: (2022)

Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII
by: Francesco Fiorentino, et al.
Published: (2023)

Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity
by: Haytham O. Tawfik, et al.
Published: (2022)

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII
by: Ashraf K. El-Damasy, et al.
Published: (2023)

S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
by: Adel S. El-Azab, et al.
Published: (2020)

Investigation of novel alkyl/benzyl (4-sulphamoylphenyl)carbamimidothioates as carbonic anhydrase inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

4-Cyanamidobenzenesulfonamide derivatives: a novel class of human and bacterial carbonic anhydrase inhibitors
by: Morteza Abdoli, et al.
Published: (2023)

4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors
by: Morteza Abdoli, et al.
Published: (2022)

Synthesis and Human Carbonic Anhydrase I, II, IX, and XII Inhibition Studies of Sulphonamides Incorporating Mono-, Bi- and Tricyclic Imide Moieties
by: Kalyan K. Sethi, et al.
Published: (2021)

Activation of human α-carbonic anhydrase isoforms I, II, IV and VII with bis-histamine schiff bases and bis-spinaceamine substituted derivatives
by: Suleyman Akocak, et al.
Published: (2019)

Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives
by: Rita Meleddu, et al.
Published: (2021)